2018:
Ahmad RS, Barritault D. ReGeneraTing Agents (RGTA®) are a new option to improve amputation outcomes in the recovery of severe hand injuries. Clin Case Rep. 2018; 6(11):2061-2069.
Fajnkuchen F, Barritault D, Giocanti-Aurégan A. Evaluation of a new matrix regenerating agent in patients with Sjögren syndrome and superficial ulcerative keratitis resistant to conventional therapy: A report of 3 cases. Medicine. 2018;97(10):e9935.
Jacquet-Guibon S, Dupays AG, Coudry V, Crevier-Denoix N, Leroy S, Siñeriz F, Chiappini F, Barritault D , Denoix JM. Randomized controlled trial demonstrates the benefit of RGTA® based matrix therapy to treat tendinopathies in racing horses. PLoS. 2018;13(3):e0191796.
Eymard F, Parsons C, Petit-Dop F, Reginster JY, Bruyère O, Chevalier X, Cooper C, Richette P. Statin use and knee osteoarthritis progression: Results from a post-hoc analysis of the SEKOIA trial. Joint Bone Spine. 2018;85:609-614.
Couraud G, Gaston AP, Tulier T, Eymard F, Hourdille A, Chevalier X, Boussion H, Guignard S.Evaluation of short-term efficacy of extraspinal cementoplasty for bone metastasis: a monocenter study of 31 patients. J Bone oncology. 2018;13:136-42.
2019:
Ahmed-Yahia S, Decousser JW, Flouzat Lachaniette CH, Dervin G, Roubineau F, Audureau E, Hourdille A, Royer G, Eymard F, Chevalier X. Is the discopathy associated with Modic changes an infectious process? Results from a prospective monocenter study. Plos One. 2019;14: e0221030.
Conrozier T, Eymard F, Chouk M, Chevalier X. Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis. BMC Musculoskel Disord. 2019; 20 :376.
Desgranges P, Louissaint T, Godeau B, Barritault D. Matrix therapy is a cost-effective solution to reduce amputation risk and improve quality of life: pilot and case studies. Regen Med Res. 2019; 7:2.
Eymard F, Chevalier X. Pharmacological treatments of knee osteoarthritis. La revue du praticien. 2019; 69 :515-519.
Martinez JA, Chiappini F, Barritault D. Case Reports for Topical Treatment of Corneal Ulcers with a New Matrix Therapy Agent or RGTA® in Dogs. Vet Sci. 2019; 6(4):103.
Migliore A, Gigliucci G, Alekseeva L, Avasthi S, Bannuru RR, Chevalier X, Conrozier T, Crimaldi S, Damjanov N, de Campos GC, Diracoglu D, Herrero-Beaumont G, Iolascon G, Ionescu R, Isailovic N, Jerosch J, Lains J, Maheu E, Makri S, Martusevich N, Matucci Cerinc M, Micu M, Pavelka K, Petrella RJ, Tarantino U, Raman R. Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statements. Ther Adv Musculoskelet Dis. 2019; 11:1759720X19893800.
Migliore A, Gigliucci G, Petrella RJ, Bannuru RR, Chevalier X , Maheu E, Raman R, Herrero-Beaumont G, Isailovic N, Matucci Cerinc M. It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis. Ther Clin Risk Manag. 2019; 15:1479-148.
Parsons CM, Judge A, Leyland K, Bruyère O, Petit Dop F, Chapurlat R, Reginster JY, Edwards MH, Dennison EM, Cooper C, Inskip H. SEKOIA Study Group. Novel Approach to Estimate Osteoarthritis Progression: Use of the Reliable Change Index in the Evaluation of Joint Space Loss. Arthritis Care Res (Hoboken). 2019; 71(2):300-307.
Roohi SA, Barritault D. ReGeneraTing Agents (RGTA®): A new option for healing and improving treatment outcomes for traumatic and burn injuries of the hand. Clin Case Rep. 2019; 7(4):619-625.
2020:
Choueiri M, Eymard F, Guignard S, Pigneur F, Chevalier X. Acute symptomatic calcific discitis mimicking a septic spondylodiscitis. Case Rep Rheumatol. 2020; 5454197.
Conrozier T, Monfort J, Chevalier X, Raman R, Richette P, Diraçoglù D, Bard H, Baron D, Jerosch J, Migliore A, Henrotin Y. EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis. Cartilage. 2020; 11(1):47-59.
Chevalier X, Sheehan B, Whittington C, Pourrahmat MM, Duarte L, Ngai W, de Campos GC. Efficacy and Safety of Hylan G-F 20 Versus Intra-Articular Corticosteroids in People with Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis. Clin Med Insights Arthritis Musculoskelet Disord. 2020; 13:1179544120967370.
Henrotin Y, Chevalier X, Raman R, Richette P, Montfort J, Jerosch J, Baron D, Bard H, Carrillon Y, Migliore A, Conrozier T. EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation. Cartilage. 2020; 11(1):60-70.
Sellam J, Courties A, Eymard F, Ferrero S, Latourte A, Ornetti P, Bannwarth B, Baumann L, Berenbaum F, Chevalier X, Ea H-K, Fabre M-C, Forestier R, Grange L, Lellouche H, Maillet J, Mainard D, Perrot S, Rannou F, Rat A-C, Roux C-H, Senbel E, Richette P. Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis. Joint Bone Spine. 2020; 87:548-555.
2021:
Avouac J, Drumez E, Hachulla E, Seror R, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Marotte H, Servettaz A, Domont F, Chazerain P, Devaux M, Claudepierre P, Langlois V, Mekinian A, Maria ATJ, Banneville B, Fautrel B, Pouchot J, Thomas T, Flipo RM, Richez C. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Lancet Rheumatol. 2021; (6):e419-e426.
Avouac J, Elhai M, Forien M, Sellam J, Eymard F, Molto A, Gossec L, Banal F, Damiano J, Dieudé P, Larger E, Allanore Y. Influence of inflammatory and non-inflammatoryrheumatic disorders on the clinical and biological profile of type-2 diabetes. Rheumatology. 2021; 60:3598-3606.
Choueiri M, Chevalier X, Eymard F. Intra-articular corticosteroids for hip osteoarthritis. A review. Cartilage. 2021; 13:122S-31S.
Conrozier T, Raman R, Chevalier X, Henrotin Y, Monfort J, Diraçoglù D, Bard H, Baron D, Jerosch J, Richette P, Migliore A. Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group. Ther Adv Musculoskelet Dis. 2021; 13:1759720X211018605.
Eymard F, Ornetti P, Maillet J, Noel E, Adam P, Legré-Boyer V, Boyer T, Allali F, Gremeaux V, Kaux JF, Louati K, Lamontagne M, Michel F, Richette P and Bard H (Groupe de Recherche sur les Injections de PRP). Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: A consensus statement from French-speaking experts. Knee Surgery Sports Traumatology Arthroscopy. 2021; 29:3195-3210.
FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients. Ann Rheum Dis. 2021; 80(4):527-538.
Henrotin Y, Tits C, Paul J, Gramme P, Helleputte T, Migliore A, Richette P, Chevalier X, Monfort J, Diracoglu D, Bard H, Jerosch J, Baron D, Raghu R, Conrozier T. Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice. Cartilage. 2021; 13(1_suppl):1696S-1701S.
Jalabert M, Ferkal S, Souberbielle JC, Sbidian E, Mageau A, Eymard F, Le Corvoisier P, Allanore L, Chevalier X, Wolkenstein P, Guignard S. Bone status according to neurofibromatosis type 1 phenotype: A descriptive study of 60 women in France. Calcif Tissue Int. 2021; 108:738-745.
Laroche JM, Kapel N, Benahmed N, Claudepierre P, Chevalier X, Barbot-Trystram L. High prevalence of small intestinal bacterial overgrowth (SIBO) in spondylarthropathy. Clin Exp Rheumatol. 2021; 39(3):703.
Migliore A, Gigliucci G, Alekseeva L, Bannuru RR, Blicharski T, Diracoglu D, Georgiadis A, Hamoud H, Martusevich N, Matucci Cerinic M, Perduk J, Szerb I, Trč T, Chevalier X. Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis. Orthop Res Rev. 2021. 13:255-273.
Pound-Lana G, Bézard P, Petit-Etienne C, Cavalaglio S, Cunge G, Cabannes-Boué B, Fleury G, Chevalier X, Zelsmann M. Dry-Etching Processes for High-Aspect-Ratio Features with Sub-10 nm Resolution High-χ Block Copolymers. ACS Appl Mater Interfaces. 2021; 13(41):49184-49193.
Richette P, Latourte A, Sellam J, Wendling D, Piperno M, Goupille P, Pers YM, Eymard F, Ottaviani S, Ornetti P, Flipo RM, Fautrel B, Bertola JP, Vicaut E, Chevalier X. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomized, placebo-controlled, multicenter trial. Ann Rheum Dis. 2021; 80:349-355.
Roohi SA, Keuylian Z, Barritault D. ReGeneraTing Agents (rgta®) technology combined with antibiotics improves outcomes for infections in the upper limb. Clin Case Rep. 2021; 9(3):1083-1091.
Sellam J, Rat AC, Fellahi S, Bastard JP, Ngueyon Sime W, Ea HK, Chevalier X, Richette P, Capeau J, Guillemin F, Berenbaum F. Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: Cross-sectional results of the KHOALA cohort. Semin Arthritis Rheum. 2021; 51(1):129-136.
Sellam J, Maheu E, Crema MD, Touati A, Courties A, Tuffet S, Rousseau A, Chevalier X, Combe B, Dougados M, Fautrel B, Kloppenburg M, Laredo JD, Loeuille D, Miquel A, Rannou F, Richette P, Simon T, Berenbaum F. The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis – methodology and baseline characteristics of the population. Joint Bone Spine. 2021; 88(4):105171.
Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry*; COVID-19 Global Rheumatology Alliance. Ann Rheum Dis. 2021; 80(7):930-942. (*We were part of the consortium).
Tiendrebeogo E, Conrozier T, Chevalier X, Eymard F. Does the presence of neuropathic pain influence the response to hyaluronic acid in patients with knee osteoarthritis. Cartilage. 2021; 13:1548S-1556S.
Thiébaut B, Bastard C, Eymard F, Bouthors C, Flouzat-Lachaniette C-H, Dubory A. Long-Term Results of Anterior-Only Lumbar Interbody Fusions in Rheumatoid Arthritis Patients: Comparative Retrospective Cohort Study. World Neurosurg. 2021; 154:e109-e117.
2022:
Berkani S, Courties A, Eymard F, Latourte A, Richette P, Berenbaum F, Sellam J, Louati K. Time to Total Knee Arthroplasty after Intra-Articular Hyaluronic Acid or Platelet-Rich Plasma Injections: A Systematic Literature Review and Meta-Analysis. J Clin Med. 2022; 11:3985.
Bourguiba R, Kyheng M, Koné-Paut I, Rouzaud D, Avouac J, Devaux M, Abdallah NA, Fautrel B, Ferreira-Maldent N, Langlois V, Ledoult E, Nielly H, Queyrel V, Sellam J, Tieulie N, Chazerain P, Evon P, Labreuche J, Savey L, Hentgen V, Grateau G, Georgin-Lavialle S. COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI – the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors*. RMD Open. 2022. 8(1). (*We were part of the consortium).
Canon A, Roy L, Chevalier X, Giraudier S, Eymard F. Calcific tendinopathy: an unexpected side effect of tyrosine kinase inhibitor? Leuk Lymphoma. 2022; 63:3175-3180.
Conrozier T, Diraçoglù D, Monfort J, Chevalier X, Bard H, Baron D, Jerosch J, Migliore A, Richette P, Henrotin Y. EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis. Cartilage. 2022; 19476035221138958.
Eymard F, Foltz V, Chemla C, Gandjbakhch F, Etchepare F, Fautrel B, Richette P, Tomi AL, Gaujoux-Viala C and Chevalier X. MRI and ultrasonography could be useful to detect early interphalangeal osteoarthritis. Joint Bone Spine. 2022; 89:105370.
Fazeli MS, McIntyre L, Huang Y, Chevalier X. Intra-articular placebo effect in the treatment of knee osteoarthritis: a survey of the current clinical evidence. Ther Adv Musculoskelet Dis. 2022; 14:1759720X211066689.
Kouki I, Sacco I, Eymard F, Fautrel B, Chevalier X, Pina Vegas L. An adult-onset Still’s disease during infection with Chlamydia trachomatis. Clin Exp Rheumatol. 2022; 40:1608.
Latourte A, Rat AC, Omorou AY, Ngueyon-Sime W, Eymard F, Sellam J, Roux C, Ea HK, Cohen-Solal M, Bardin T, Baudreuil J, Guillemin F, Richette P. Do Glucocorticoid Injections Increase the Risk of Knee Osteoarthritis Progression Over 5 Years?. Arthritis Rheumatology. 2022; 74:1343-1351.
Maugard Y, Bard L, Latourte A, Senbel E, Flipo RM, Eymard F. Musculoskeletal corticosteroid injections: Recommendations of the French Society for Rheumatology (SFR). Joint Bone Spine. 2022; 90:105515.
2023:
Cambon-Binder A, Jaisson S, Tuffet S, Courties A, Eymard F, Okwieka A, Gillery P, Miquel A, Rousseau A, Crema MD, Berenbaum F, Sellam J. Serum carboxymethyllysine concentration is associated with erosive hand osteoarthritis. Osteoarthritis Cartilage. 2023; 31(7):976-984.
Eymard F, Aron-Wisnewsky. Osteoarthritis in patients with obesity: the bariatric surgery impacts on its evolution. Joint Bone Spine. 2023; 91(2):105639.
Hugues B, Emsen B, Pina Vegas L, Lepeule R, Ternacle J, Huguet R, Decousser JW, Fiore A, Lim P, Itti E, Chevalier X, Abulizi M, Eymard F. PET/CT for osteoarticular septic grafts in endocarditis: Results from a large monocentric cohort. Joint Bone Spine. 2023; 90(5):105577.
Even B, Eymard F, and Albanese P. « Matrice cartilagineuse et arthrose : retour aux sources des sucres ». Revue du Rhumatisme 91. 2024 ; no 3: 338 46. https://doi.org/10.1016/j.rhum.2023.11.007
2024:
Saadan C, Flageollet C, Albanese P, and Eymard F. « Caractérisation de la compo- sante glycanique du Plasma Riche en Plaquettes dans l’arthrose », s. d. Actualités en médecine régénérative musculosquelettique. 2024.
Laisser un commentaire